Does a CT Scan Show Multiple Sclerosis (MS)?

A CT scan can occasionally reveal signs of multiple sclerosis, but it misses the majority of lesions and is not reliable enough to diagnose or rule out the disease. Early studies comparing the two imaging methods found that CT detected abnormalities in roughly a quarter to half of confirmed MS patients, while MRI picked up lesions in nearly all of them. That enormous sensitivity gap is why MRI became the backbone of MS diagnosis decades ago, and why a normal CT result should never be taken as reassurance that MS is absent.

What a CT Scan Can Actually Show

CT is not completely blind to MS. In people with well-established disease, a CT scan sometimes reveals patches of low density in the white matter, particularly around the front and back horns of the lateral ventricles. A 1976 study of 110 MS patients found these periventricular low-density areas in about 37% of cases, and the researchers noted that the locations matched the classic large plaques pathologists had long described at autopsy.¹ When contrast dye is injected, CT can also detect areas of active inflammation where the blood-brain barrier has broken down. In one study, patients with definite MS who had experienced a recent clinical flare showed abnormal contrast enhancement on CT in about 89% of cases.²

Over the long term, CT can also pick up cerebral atrophy, the gradual loss of brain volume that results from years of demyelination and tissue scarring. Atrophy is a common feature in MS and shows up as widened ventricles and sulci on a CT scan.³ So it is not that CT reveals nothing. The problem is what it routinely misses.

Why CT Misses Most MS Lesions

The contrast between normal white matter and an MS plaque is subtle on CT. Demyelination changes the tissue’s density only slightly, and CT simply does not resolve those small differences well, especially when the lesions are small or sitting in areas surrounded by bone (like the brainstem or spinal cord). MRI, by contrast, is exquisitely sensitive to the water-content changes that demyelination produces, which is why it lights up lesions that CT cannot see.

The numbers from head-to-head comparisons are striking. In a study of 39 patients, MRI detected characteristic abnormalities in every single case, whereas CT was positive in only 15 of 33 patients who received both scans. Milder grades of disease were usually invisible to CT entirely, and even when CT did spot something, MRI revealed the disease to be far more extensive.⁴ A separate comparison in 74 patients with definite MS found CT positive in just 25% of them. Crucially, MRI was always positive whenever CT was positive, meaning CT never caught anything MRI missed.⁵

A Canadian study reinforced the point from a diagnostic standpoint. Among patients with chronic, well-documented MS, MRI made the diagnosis in 97% of cases. A specialized high-volume delayed CT technique, which was considered state-of-the-art at the time, managed only 54% of a subset who underwent it. For newly suspected cases that were later confirmed by a neurologist, MRI identified 88% while CT identified just 52%.⁶ The conclusion across all of these studies was unanimous: MRI could effectively replace CT for MS diagnosis.

Acute Flares and the Emergency Room Scenario

If you arrive at an emergency department with sudden neurological symptoms, you will almost certainly get a CT scan first. That is because CT is fast, widely available, and excellent at ruling out strokes, bleeds, and large tumors, all of which can mimic an MS attack and need immediate treatment. In that context, the CT is doing its intended job even though it is poor at detecting MS specifically.

During an acute MS flare, CT occasionally reveals contrast-enhancing lesions in the periventricular and deep white matter. Early research showed that these enhanced spots evolve over time, either fading to match the surrounding tissue or leaving behind low-density scars, consistent with the cycle of active demyelination followed by partial healing.⁷ But the sensitivity during an acute episode remains unreliable for milder or smaller attacks. The real value of an emergency CT in a possible MS case is what it rules out, not what it rules in. If the CT is normal but the symptoms are suggestive, the next step is an MRI.

One Situation Where CT Adds Real Value

There is an uncommon variant of MS called tumefactive MS, where lesions grow large enough to look like brain tumors on imaging. These lesions can cause mass effect, swelling, and ring-shaped enhancement, making them virtually indistinguishable from gliomas or brain abscesses on standard contrast-enhanced MRI.⁸ Patients with tumefactive MS have undergone unnecessary brain biopsies and even started chemotherapy before the real diagnosis was sorted out.⁹

Here, a plain unenhanced CT scan turns out to be surprisingly helpful. In a study comparing tumefactive demyelinating lesions with brain tumors, researchers looked at how the areas that lit up on MRI appeared on a corresponding unenhanced CT. In 93% of patients with demyelinating lesions, those MRI-enhancing regions appeared dark (low-density) on CT. Only 4% of actual tumor patients showed the same pattern. The density difference was statistically dramatic.¹⁰ In other words, if MRI shows an enhancing mass that looks like a tumor but CT shows that same area as conspicuously low-density, demyelination jumps to the top of the list. It is an uncommon scenario, but one where CT punches above its weight.

How MS Is Actually Diagnosed

Modern MS diagnosis revolves around demonstrating that inflammatory lesions have occurred in more than one location in the central nervous system and at more than one point in time. The formal system for establishing this is the McDonald criteria, which have been revised multiple times and were most recently updated in 2024. MRI is the centerpiece. The 2010 revision simplified things so that, in some circumstances, a single MRI scan can establish both the spatial and temporal spread of disease.¹¹

The 2024 revision went further. The optic nerve was added as a fifth anatomical location that can count toward spatial spread, and new MRI-specific features, including the central vein sign and paramagnetic rim lesions, were incorporated as supportive evidence for the diagnosis.¹² These are findings that only MRI can detect. CT plays no role in the McDonald criteria at any revision. The diagnostic framework for MS has been built entirely around MRI’s capabilities for over two decades.

The Danger of Stopping at a Normal CT

Because CT misses the majority of MS lesions, treating a normal CT as a clean bill of health carries real consequences. A study examining diagnostic delay in MS identified specific clinical pitfalls that led to people going undiagnosed for years. One recognized scenario was the exclusion of MS based on a normal brain CT without any follow-up MRI or continued clinical monitoring.¹³ In practical terms, a person might show up with optic neuritis, numbness, or balance problems, get a CT scan that looks normal, and be told nothing is wrong. Years later, after more attacks and accumulating disability, MS is finally diagnosed.

This matters because earlier diagnosis and earlier treatment generally translate to better long-term outcomes in MS. Disease-modifying therapies are most effective when started before significant disability has accumulated. A missed opportunity for an MRI at first presentation can mean lost time that treatments cannot fully recover.

Other Tests That Help Clinch the Diagnosis

MRI does the heavy lifting, but it is not the only tool neurologists rely on. Cerebrospinal fluid analysis, obtained through a lumbar puncture, can detect oligoclonal bands, which are specific antibody patterns produced inside the central nervous system. A large retrospective analysis found that these bands had a sensitivity of about 93% and a specificity of about 90% for MS. The negative predictive value was especially strong: if oligoclonal bands are absent, the chance that the person has MS is very low.¹⁴ The 2024 McDonald criteria also incorporated kappa free light chain concentrations in cerebrospinal fluid as a newer supporting biomarker.¹²

Visual evoked potentials, which measure how quickly electrical signals travel from the eye to the brain, can reveal slowed nerve conduction caused by demyelination of the optic nerve. Even when someone has not noticed visual symptoms, evoked potentials can pick up subclinical damage. In one study of MS patients, visual evoked potentials were abnormal in 40% of eyes that had no history of optic neuritis, compared to 19% detected by optical coherence tomography. Combining the two tests pushed sensitivity to 44% in those eyes without prior symptoms.¹⁵ Research has also suggested that using lower-contrast visual stimuli makes evoked potential testing even more sensitive for detecting a first episode of optic neuritis.¹⁶

None of these tests replace MRI, but they add diagnostic confidence and can provide evidence of disease activity in places MRI struggles to image well. Even MRI has blind spots: small lesions in the brainstem, cerebellum, and spinal cord can be clinically significant yet invisible on the scan.⁶

What CT and MRI Are Actually Seeing at the Tissue Level

Understanding what each imaging method detects helps explain why CT falls so far behind. In MS, the immune system strips the myelin sheath from nerve fibers, leaving behind patches of inflammation that gradually resolve into scar tissue. A histopathological study that correlated biopsy and autopsy findings with both CT and MRI results identified three broad radiological patterns. Active lesions tended to show ring-shaped contrast enhancement on both modalities, corresponding to zones of active demyelination with a leaky blood-brain barrier. Inactive, scarred lesions appeared uniformly low-density on CT and had a characteristic bright signal on certain MRI sequences.¹⁷

The key difference is that MRI’s signal-intensity changes are far more conspicuous than CT’s subtle density shifts. On MRI, a demyelinated plaque practically announces itself against the surrounding normal white matter. On CT, the density difference between a plaque and healthy tissue can be so small that the lesion blends in, especially if it is not actively inflamed. This is a fundamental limitation of how CT generates images, not something that better scanner hardware or technique can fully overcome.

When MRI Is Not Available

In parts of the world where MRI scanners are scarce, CT may still be the only cross-sectional imaging available. This creates a genuine clinical dilemma. A normal CT does not exclude MS, and the formal diagnostic criteria require MRI-based evidence. Clinicians in resource-limited settings sometimes have to rely more heavily on clinical history, cerebrospinal fluid analysis, and evoked potential testing to build a case for MS when MRI is inaccessible. The 2024 McDonald criteria tried to broaden the toolkit by incorporating laboratory biomarkers that do not require imaging, but the diagnostic framework still depends on MRI for its core logic.

For patients who cannot undergo MRI because of certain implanted devices, severe claustrophobia, or body habitus that exceeds scanner limits, the options are more constrained. Open MRI machines and sedation protocols can solve some of these problems. CT with contrast may pick up large, active lesions, but a negative CT in that scenario tells you almost nothing about whether MS is present. Clinicians in these situations often treat the diagnosis as provisional and rely on clinical follow-up, repeating imaging attempts when circumstances change.

Practical Takeaways if You Have Had a CT

If you went to the emergency room with neurological symptoms and your CT came back normal, that result is genuinely reassuring for ruling out a stroke or a large brain mass. It is not reassuring for MS. If your symptoms include things like episodes of numbness or tingling, vision problems in one eye, unexplained balance issues, or limb weakness that comes and goes, a normal CT should be followed by a conversation with your doctor about whether an MRI is warranted. Do not let a clean CT scan close the book on investigation.

If you already have diagnosed MS and a CT was performed for some other reason, the scan might show some periventricular changes or atrophy, but it will almost certainly underestimate the true extent of your disease. MRI remains the tool for monitoring disease activity, tracking new or enlarging lesions, and evaluating whether your treatment is working. CT serves a different purpose in your medical care and should not be used as a substitute for routine MRI surveillance of MS.